Drug profile · INN
bexarotene
TARGRETIN
bexarotene (TARGRETIN) is a retinoid x receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Drug details — bexarotene
- US status
- approved
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- TOPICAL
- Patents
- 20
- Programs
- 12
- Data quality
- 0.89
Quick answer
bexarotene (TARGRETIN) is a retinoid x receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Retinoid X receptor agonist
Primary target: Retinoid X receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12123012
Methods and compositions for nucleic acid and protein payload delivery
granted -
US 11970482
Acetal compounds and therapeutic uses thereof
granted -
US 11773110
Heterocycle amines and uses thereof
granted -
US 11566041
Nucleotide prodrug compounds
granted -
US 11278559
Prodrug compounds and their uses
granted -
US 11186593
Heterocycle amines and uses thereof
granted -
US 10975388
Methods and compositions for nucleic acid and protein payload delivery
granted -
US 10874638
Methods and compositions for modulating hormone levels
granted -
US 10604533
Heterocycle amines and uses thereof
granted -
US 10449210
Prodrug compounds and their uses
granted -
US 10441567
Methods and compositions for modulating hormone levels
granted -
US 10150788
Prodrug compounds and uses thereof
granted -
US 10030034
Heterocycle amines and uses thereof
granted -
US 9994600
Prodrug compounds and uses therof
granted -
US 9662312
Method for treating glomerulosclerosis
granted -
US 9326991
Nucleotide prodrug compounds and use
granted -
US 9266874
Heterocycle amines and uses thereof
granted -
US 9174917
Bexarotene analogs
granted -
US 7919248
Methods for the modulation of IL-13
granted -
US 7691895
Thrombopoietin activity modulating compounds and methods
granted
Frequently asked questions
What is bexarotene?
bexarotene (TARGRETIN) is a retinoid x receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for bexarotene?
TARGRETIN is a marketed brand name for bexarotene. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bexarotene?
bexarotene has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.